Buccal versus Vaginal (200 microgram) Misoprostol for Second Trimester Abortion Terminatio

Completed

• Conditions: Missed Abortion; Intrauterine fetal death; Reproductive Health and Childbirth - Abortion

• Registration Number: ACTRN12615000483550
• Lead Sponsor: women health hospital of assuit university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-05-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 180

Inclusion Criteria

1-Women who are pregnant between 13 and 27 weeks.
2- Termination of pregnancy is indicated due to intrauterine fetal death.

Exclusion Criteria

1-Pregnancy before 13 weeks.
2-Pregnancy beyond 27 weeks.
3- Scarred uterus.
4-Known hypersensitivity for misoprostol.
5-Refusal of the woman to participate.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome measure is the induction interval, the time from the initial misoprostol dose until complete fetal expulsion.[at time of complete fetal expulsion ]

Secondary Outcome Measures

Name	Time	Method
Incidence of side effects of misoprostol (such as nausea, vomiting, fever, chills, diarrhea, tachycardia, and headache)[untill complete fetal expulsion];number of misoprostol doses[till time of expulsion for maximum 24 hours]